MICB and neoplasm: The Anti-MICB-CAR-NK possesses two key highlights: First, it secretes a free Anti-MICB-scFv fragment, which prevents the shedding of MICB from the tumor cell surface and may thereby activate immune cells such as T cells, γδT cells, and NK cells to attacking the tumor.